ALIGOS Therapeutics
  • About
    • Overview
    • Management
    • Board of Directors
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • MASH
    • CHB
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • News Releases
      • Investor Calendar
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers
  • About
    • Overview
    • Management
    • Board of Directors
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • MASH
    • CHB
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • News Releases
      • Investor Calendar
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers

Investor Relations

Investors

US OFFICE
1 Corporate Dr., 2nd Floor
South San Francisco, CA 94080

EU OFFICE
Gaston Geenslaan 1 / (Building 3)
3001 Leuven, Belgium

CHINA OFFICE
Unit 3212, Building A, No. 100, Zunyi Road, Changning District, Shanghai, People’s Republic of China, 200051

FOLLOW US

info@aligos.com

© Aligos Therapeutics 2024

  • Privacy Policy
  • Terms of Service
MENU
  • About
    • Overview
    • Management
    • Board of Directors
  • Science
    • Pipeline
    • Posters & Presentations
  • Patients
    • MASH
    • CHB
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations & Events
  • Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • News Releases
      • Investor Calendar
    • Financials
      • SEC Filings
      • Quarterly Results
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Careers